|Articles|December 8, 2011

Video blog: BOLERO-2 and Afinitor in breast cancer

Dr. Debu Tripathy explains the updated results of the BOLERO-2 study, which looked at Afinitor (everolimus) and an aromatase inhibitor in metastatic breast cancer. How useful will this new drug be in metastatic breast cancer?

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!

Related Content

Chronic Myeloid Leukemia: From Diagnosis to Ongoing Management

ByRyan Scott

January 18th 2026

Stage 4 Papillary Thyroid Cancer: A Guide to Diagnosis, Treatment and Management

ByGina Mauro

January 18th 2026

Uveal Melanoma Guide: An Overview From Diagnosis to Treatment and Beyond

ByAlex Biese

January 17th 2026

Large Cell Lung Cancer Overview: What Patients Need to Know

ByCURE staff

January 17th 2026

My name is Beth Kramer, and I am 58 years old, and I have faced cancer three times: © stock.adobe.com.

My Three-Time Cancer Journey

ByBeth Kramer

January 16th 2026

Video blog: BOLERO-2 and Afinitor in breast cancer

Newsletter

Related Content

Chronic Myeloid Leukemia: From Diagnosis to Ongoing Management

Stage 4 Papillary Thyroid Cancer: A Guide to Diagnosis, Treatment and Management

Uveal Melanoma Guide: An Overview From Diagnosis to Treatment and Beyond

Large Cell Lung Cancer Overview: What Patients Need to Know

My Three-Time Cancer Journey

Trending on CURE

Given Months to Live, She’s Now a Five-Year Glioblastoma Survivor

Uveal Melanoma Guide: An Overview From Diagnosis to Treatment and Beyond

My Three-Time Cancer Journey

Chronic Myeloid Leukemia: From Diagnosis to Ongoing Management

Tecvayli With Darzalex Could Be ‘Truly Transformative’ in Multiple Myeloma